Standout Papers

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic R... 1998 2026 2007 2016 728
  1. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma (1998)
    Sylvie Négrier, Bernard Escudier et al. New England Journal of Medicine

Immediate Impact

9 by Nobel laureates 18 from Science/Nature 65 standout
Sub-graph 1 of 17

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Tertiary lymphoid structures in cancer
2022 StandoutScience
2 intermediate papers

Works of J. Savary being referenced

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
1998 Standout

Author Peers

Author Last Decade Papers Cites
J. Savary 507 503 25 677 24 1.2k
Daniel Sudilovsky 692 615 24 501 32 1.6k
Julia Wilkerson 493 585 84 676 44 1.7k
Abdel‐Aziz A. Elgamal 395 232 13 892 24 1.4k
Håkon Wæhre 434 378 59 539 47 1.4k
Matteo Rosellini 373 565 17 639 47 1.2k
H Sawada 662 498 17 396 38 1.3k
Wulf Sienel 382 557 9 499 41 1.3k
Ann Koons 529 443 93 439 27 1.7k
Diane Savarese 271 567 31 516 24 1.2k
Guosheng Feng 807 660 52 414 39 1.7k

All Works

Loading papers...

Rankless by CCL
2026